$EXAS Recent News My long, profitable relationship with

New Post Public Reply Private Reply Replies (0) Message Board

Feb 13, 2015 at 12:08 PM

$EXAS Recent News

My long, profitable relationship with Exact Sciences 12:01 a.m. Today - Kirk Spano
Fifteen stocks for 2015, part 1 10:36 a.m. Jan. 9, 2015 - The Trading Deck
The ‘next great investing columnist’ looks back — and ahead 12:04 p.m. Dec. 31, 2014 - The Trading Deck
5 stocks to watch 10:46 a.m. Nov. 26, 2014 - The Trading Deck
A fairly valued market may mean gains in 2015 4:57 a.m. Nov. 24, 2014 - MarketWatch
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
S&P 500, Nasdaq suffer worst weekly loss since May 2012 3:26 p.m. Oct. 10, 2014 - Anora Mahmudova
Exact Sciences shares rise on cancer-test reimbursement 8:06 a.m. Oct. 10, 2014 - Chelsey Dulaney
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
FDA approves DNA test for colon cancer 6:07 a.m. Aug. 12, 2014 - Joseph Walker
Puma Biotech’s blast-off is not a typical short squeeze 11:10 a.m. July 23, 2014 - Tomi Kilgore
6 stocks to watch 2:41 p.m. July 16, 2014 - The Trading Deck
Fourteen stocks for 2014 halftime report 10:49 a.m. July 8, 2014 - The Trading Deck
A very Exact opportunity in biotech 11:06 a.m. April 4, 2014 - The Trading Deck
Investors let air out of biotech amid overheating, pricing concerns 12:42 p.m. March 21, 2014 - Russ Britt
Mayo takes the rap for Exact's test leak, but stock gain remains a puzzle 3:48 p.m. March 19, 2014 - Russ Britt
Company's plan to release positive cancer screening results goes awry 11:24 a.m. March 19, 2014 - Russ Britt
Fourteen stocks for 2014 12:02 a.m. Jan. 7, 2014 - Kirk Spano
Biotech volatility can mean danger or opportunity 12:09 p.m. Oct. 23, 2013 - The Trading Deck
Three calls with big upside 12:14 p.m. Sept. 25, 2013 - The Trading Deck

VolitionRx: The Future Of Cancer Screening 9:18 a.m. Feb. 12, 2015 - Seeking Alpha
Swiss diagnostics firm acquires CRC molecular blood test 7:57 a.m. Feb. 12, 2015 - Seeking Alpha
5 Stocks With Ugly Sales Growth — RNA IFT CBMG CCXI EXAS 2:45 a.m. Feb. 9, 2015 - InvestorPlace.com
'Fast Money' Recap: How to Trade in a Gyrating Stock Market 5:00 a.m. Feb. 7, 2015 - TheStreet.com
Check-Cap on deck for IPO 12:29 p.m. Feb. 6, 2015 - Seeking Alpha
5 Stocks With Bad Sales Growth — RNA IFT CBMG CCXI EXAS 4:30 a.m. Feb. 2, 2015 - InvestorPlace.com
5 Stocks With Poor Sales Growth — RNA IFT CBMG CCXI EXAS 1:15 a.m. Jan. 26, 2015 - InvestorPlace.com
Exact Sciences' Puzzling Early Launch Trajectory Update For Cologuard - An Analysis 6:30 a.m. Jan. 21, 2015 - Seeking Alpha
5 Stocks With Crummy Sales Growth — RNA IFT CBMG CCXI EXAS 2:30 a.m. Jan. 20, 2015 - InvestorPlace.com
A Rare Bogey for Barron’s 12:45 a.m. Jan. 17, 2015 - Barrons.com
Biggest Movers in Healthcare Stocks Now – LH GSK PCRX ACHN 12:30 p.m. Jan. 15, 2015 - InvestorPlace.com
The Liquid Biopsy Will Boost Revenue For Sequenom And Illumina 11:36 a.m. Jan. 15, 2015 - Seeking Alpha
Why You Shouldn't Bet Against Exact Sciences (EXAS) Stock - Tale of the Tape 8:40 a.m. Jan. 13, 2015 - Zacks.com
Exact Sciences reports Cologuard volume for 2014 12:58 p.m. Jan. 12, 2015 - Seeking Alpha
5 Stocks With Bad Sales Growth — RNA IFT CBMG CCXI EXAS 1:45 a.m. Jan. 12, 2015 - InvestorPlace.com
Interesting EXAS Put And Call Options For February 20th 11:05 a.m. Jan. 6, 2015 - TheStreet.com
UPDATE: Lake Street Initiates Coverage On EXACT Sciences 10:36 a.m. Jan. 5, 2015 - benzinga.com
Final Medicare reimbursement set for Cologuard 9:49 a.m. Jan. 2, 2015 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – ACHN EXAS CBPO ABMD 7:30 a.m. Dec. 22, 2014 - InvestorPlace.com

Exact Sciences Names Michael S. Wygza to its Board of Directors 10:32 a.m. Feb. 11, 2015 - BusinessWire - BZX
Exact Sciences to Participate in Leerink Global Healthcare Conference 4:31 p.m. Feb. 5, 2015 - BusinessWire - BZX
Exact Sciences Announces Norton Healthcare to Adopt Cologuard 3:30 p.m. Jan. 28, 2015 - BusinessWire - BZX
Exact Sciences Offers Update on Cologuard’s® Early Launch Trajectory 9:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Exact Sciences Names Scott Coward as General Counsel 10:18 a.m. Jan. 9, 2015 - BusinessWire - BZX
Exact Sciences to participate in J.P. Morgan Healthcare Conference 4:30 p.m. Jan. 6, 2015 - BusinessWire - BZX
Exact Sciences: Additional Update on CMS Reimbursement for Cologuard® 8:00 a.m. Jan. 2, 2015 - BusinessWire - BZX
Technical Commentary on Pharma Stocks -- AstraZeneca, Horizon Pharma, Valeant Pharma Intl., Exact Sciences, and Novo Nordisk 8:40 a.m. Dec. 29, 2014 - PR Newswire - PRF
Update on CMS Reimbursement for Cologuard® 5:30 p.m. Dec. 19, 2014 - BusinessWire - BZX
Exact Sciences Addresses CMS Reimbursement for Cologuard® 3:30 p.m. Dec. 19, 2014 - BusinessWire - BZX
Exact Sciences Announces Pricing of Public Offering of Common Stock 9:10 a.m. Dec. 16, 2014 - BusinessWire - BZX
Exact Sciences Announces Agreement to Sell 4,000,000 Common Shares 4:08 p.m. Dec. 15, 2014 - BusinessWire - BZX
Exact Sciences Announces Mercy Hospital St. Louis Now Offering Cologuard® 8:04 a.m. Dec. 2, 2014 - BusinessWire - BZX
Exact Sciences Announces Final Payment Decision for Cologuard® from the Centers for Medicare & Medicaid Services 12:43 p.m. Nov. 25, 2014 - BusinessWire - BZX
Cologuard® Wins Popular Science Magazine’s 2014 “Best of What's New” Award 12:30 p.m. Nov. 12, 2014 - BusinessWire - BZX
VYCOR: "On the Cusp of the Next Big Healthcare Trend" 9:23 a.m. Nov. 10, 2014 - ACCESSWIRE
Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics 9:05 a.m. Nov. 10, 2014 - PR Newswire - PRF
American Cancer Society Includes Exact Sciences’ Cologuard in Colorectal Cancer Prevention and Early Detection Guidelines 8:03 a.m. Nov. 6, 2014 - BusinessWire - BZX
Exact Sciences to Participate in November Conferences 4:33 p.m. Nov. 5, 2014 - BusinessWire - BZX
Exact Sciences Announces Meriter-UnityPoint Health Now Offering Cologuard® 8:01 a.m. Oct. 29, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....